Switzerland
Dr Alex Mesoudi, from Queen Mary's newly established Research Centre for Psychology, has found evidence that the increasing reach and influence of the media, combined with a growing number of people assigned celebrity status, could increase the probability of widespread suicide pandemics. The study is published today in the peer reviewed journal PLoS ONE.
SINGAPORE -- September 2009 -- Converting the trash that fills the world's landfills into biofuel may be the answer to both the growing energy crisis and to tackling carbon emissions, claim scientists in Singapore and Switzerland.
Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. That is the finding of a new study from Swiss researchers to be published in the December 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
Berlin, Germany: At least 124,000 new cancers in 2008 in Europe may have been caused by excess body weight, according to estimates from a new modelling study. The proportion of cases of new cancers attributable to a body mass index of 25kg/m2 or more were highest among women and in central European countries such as the Czech Republic, Latvia, Slovenia and Bulgaria.
The Indian launcher Polar Space Launch Vehicle took off at 8:22 a.m. - Swiss time. Twenty minutes later, the SwissCube was ejected from the nose cone of the rocket at an altitude of around 720 kilometers. At 9:37 a.m. the first ever signals sent from a Swiss satellite in space were picked up from Stanford (California). Mission accomplished.
This 34 by 20-degree wide image provides us with a view as experienced by amateur astronomers around the world. However, its incredible beauty and appeal owe much to the quality of the observing site and the skills of Stéphane Guisard, the world-renowned astrophotographer, who is also an ESO engineer.
The longest set of HARPS measurements ever made has firmly established the nature of the smallest and fastest-orbiting exoplanet known, CoRoT-7b, revealing its mass as five times that of Earth's.
Processes and policies governing the reuse and recycling of electronic products need to be standardized worldwide to stem and reverse the growing problem of illegal and harmful e-waste processing practices in developing countries, according to experts behind the world's first international e-waste academy.
The first of three images of ESO's GigaGalaxy Zoom project -- a new magnificent 800-million-pixel panorama of the entire sky as seen from ESO's observing sites in Chile -- has just been released online. The project allows stargazers to explore and experience the Universe as it is seen with the unaided eye from the darkest and best viewing locations in the world.
CAMBRIDGE, MA -- Sept. 11, 2009 -- Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon beta-1a IM) reported significantly fewer injection site reactions (ISRs) compared to patients on Betaferon® (interferon beta-1b), Copaxone® (glatiramer Acetate) or Rebif ® (interferon beta-1a).
Lisbon, Portugal 11 September, 2009 -- The first results of the first European survey of cancer patients? experience of breakthrough pain were presented today at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC).
Lisbon, Portugal 11 September, 2009 -- New data presented today further demonstrate the efficacy of Instanyl in management of breakthrough cancer pain.
One Million Swiss Francs (Around $ 940 Thousand, € 660 Thousand) for Each Subject.
Half of the Amount Must be Destined to Research
Milan, September 7, 2009 - The names of the 2009 Balzan Prize winners were
announced today:
TERENCE CAVE (UK), St John's College, Oxford, for Literature since 1500
PAOLO ROSSI (Italy), Università di Firenze, for History of Science
Barcelona, Spain, 1 September: The European cardiac resynchronization therapy (CRT) Survey is a joint initiative taken by the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology.
Lausanne, Switzerland -- Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, today announced the publication of interim results from a phase II study suggesting that the antisense oligonucleotide GS-101 (eye drops) is safe and effective at inhibiting and regressing corneal neovascularisation (abnormal new blood vessel growth).
